← Eichor
Study identifier: NCT07628400 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Comparative Effects of Hypopressive and Split Tummy Exercises in Postpartum Diastasis Recti

Condition: Diastasis Recti  ·  Sponsor: Riphah International University

PhaseNA
Planned participants50
Who can joinFemale, 24 Years to 40 Years
Healthy volunteersNo

About this study

To compare the effects of hypopressive exercises and split tummy (transverse abdominal activation-based) exercises on inter-recti distance (IRD), pelvic floor muscle strength and function, and overall quality of life improvements in postpartum women with diastasis recti. This study will be randomized clinical trial and will be conducted in Hameed Latif Hospital Lahore and Civil Hospital Sukkur. The total duration of treatment will be 8 week. Non-probability convenience sampling technique will be used and 50 participants will be recruited in study after randomization. The subjects will be divided into two groups. Group A will receive hypopressive exercise with baseline treatment abdominal binding. Group B will receive baseline treatment with split tummy exercises.

This description comes directly from the study's public registry record.

Talk to the study team

Imran Amjad, PhD  ·  03324390125  ·  imran.amjad@riphah.edu.pk

Always discuss trial participation with your own doctor first.

Locations (1)

Civil Hospital SukkurSukkur, Punjab Province, PakistanRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07628400